CytRx Corporation to Present at the Rodman & Renshaw Global Investment Conference

Published: Sep 03, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, announces that President and CEO Steven A. Kriegsman and Vice President of Business Development David J. Haen will present at the Rodman & Renshaw Global Investment Conference on Monday, September 9, 2013, at 10:50 a.m. Eastern time (7:50 a.m. Pacific time). The conference is being held at the Millennium Broadway Hotel in New York City.

Help employers find you! Check out all the jobs and post your resume.

Back to news